Clinical significance and prognostic value of circulating B10 cells in colorectal cancer
- 27 July 2021
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 18 (2) , E157-E162
Abstract
Background: B10 cells, a subset of regulatory B cells, can inhibit antitumor response and thus promote tumor development. This study explored the clinical meaning and prognostic value of circulating B10 cells in colorectal cancer (CRC).Materials and methods: The proportion of B10 cells in peripheral blood in CRC patients and healthy controls was detected by multicolor flow cytometry.Results: The proportion of circulating B10 cells was remarkably elevated in CRC patients compared to normal controls (% of CD19+B cells; 16.6% (IQR 6.0%) versus 9.0% (IQR 5.7%), p < 0.001). B10 cells proportion was associated with tumor size, depth of invasion, lymph node metastasis, and TNM stage in CRC. Kaplan–Meier analysis indicated that CRC patients with high B10 cells proportion suffered worse overall survival than those with low B10 cells proportion. Multivariate analysis revealed that the proportion of B10 cells was an independent prognostic indicator for CRC patients.Conclusion: Our results indicate that the proportion of circulating B10 cells is an independent prognostic factor for patients with CRC and thus may help guide the clinical decision in CRC.Keywords
This publication has 22 references indexed in Scilit:
- Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual PatientsJournal of Clinical Oncology, 2015
- Regulatory B Cells: Origin, Phenotype, and FunctionImmunity, 2015
- B10 Cells: A Functionally Defined Regulatory B Cell SubsetThe Journal of Immunology, 2015
- Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancerJournal of Translational Medicine, 2014
- Colorectal cancerThe Lancet, 2014
- IL-10-producing regulatory B cells (B10 cells) in autoimmune diseaseArthritis Research & Therapy, 2013
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive functionLeukemia, 2012
- Immune Regulatory Function of B CellsAnnual Review of Immunology, 2012
- Identifying Regulatory B Cells (B10 Cells) that Produce IL-10 in Mice2010
- B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancerAnnals of the New York Academy of Sciences, 2010